Menu +

Tag: pharmaceutical

EU Commission Pharmaceutical Strategy for Europe -Affordable, accessible and safe medicines for all

The Commission has today adopted a Pharmaceutical Strategy for Europe to ensure patients have access to innovative and affordable medicines and to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry. The Strategy will allow Europe to cover its pharmaceutical needs, including in times of crisis, through robust supply chains. A key […]

Pharmaceutical Strategy: European Commission launches online public consultation

Today, the European Commission is launching an online public consultation on the Pharmaceutical Strategy for Europe. The consultation will last three months and consists of questions which will focus on key themes: strategic autonomy and manufacturing of medicines, access to affordable medicines, innovation, and environmental sustainability and health challenges. The results of the public consultation […]

2. MANUFACTURING, IMPORTATION OF FINISHED PRODUCTS AND ACTIVE PHARMACEUTICAL INGREDIENTS AND GMP AND GDP ISSUES

QUESTIONS AND ANSWERS ON REGULATORY EXPECTATIONS FOR MEDICINAL PRODUCTS FOR HUMAN USE DURING THE COVID-19 PANDEMIC 2.1. How can changes in the manufacturing/supply chain be implemented swiftly to ensure continuity of supplies to the EU of crucial medicines for treatment of COVID-19 patients? MAHs may experience supply chain/manufacturing disruptions due to manufacturing, distribution and trade […]